VOYA Investment Management
RVNC

VOYA Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,975
Closed -$97.2K 2755
2024
Q4
$97.2K Sell
31,975
-2,183
-6% -$6.64K ﹤0.01% 2583
2024
Q3
$177K Sell
34,158
-1,226
-3% -$6.36K ﹤0.01% 2520
2024
Q2
$90.9K Buy
35,384
+6,618
+23% +$17K ﹤0.01% 2690
2024
Q1
$142K Sell
28,766
-5,435
-16% -$26.7K ﹤0.01% 2548
2023
Q4
$301K Buy
34,201
+683
+2% +$6K ﹤0.01% 2346
2023
Q3
$384K Buy
33,518
+393
+1% +$4.51K ﹤0.01% 2184
2023
Q2
$838K Buy
33,125
+2,603
+9% +$65.9K ﹤0.01% 1774
2023
Q1
$983K Hold
30,522
﹤0.01% 1666
2022
Q4
$563K Buy
30,522
+2,775
+10% +$51.2K ﹤0.01% 1969
2022
Q3
$749K Buy
27,747
+593
+2% +$16K ﹤0.01% 1786
2022
Q2
$375K Sell
27,154
-591
-2% -$8.16K ﹤0.01% 2018
2022
Q1
$541K Hold
27,745
﹤0.01% 1863
2021
Q4
$453K Buy
27,745
+327
+1% +$5.34K ﹤0.01% 2082
2021
Q3
$764K Hold
27,418
﹤0.01% 1773
2021
Q2
$813K Sell
27,418
-271
-1% -$8.04K ﹤0.01% 1793
2021
Q1
$774K Buy
27,689
+60
+0.2% +$1.68K ﹤0.01% 1754
2020
Q4
$783K Buy
27,629
+6,619
+32% +$188K ﹤0.01% 1645
2020
Q3
$528K Buy
21,010
+946
+5% +$23.8K ﹤0.01% 1645
2020
Q2
$490K Sell
20,064
-5,027
-20% -$123K ﹤0.01% 1681
2020
Q1
$371K Buy
25,091
+3,253
+15% +$48.1K ﹤0.01% 1807
2019
Q4
$354K Buy
21,838
+5,330
+32% +$86.4K ﹤0.01% 2088
2019
Q3
$215K Buy
16,508
+733
+5% +$9.55K ﹤0.01% 2218
2019
Q2
$205K Buy
15,775
+2,169
+16% +$28.2K ﹤0.01% 2298
2019
Q1
$214K Hold
13,606
﹤0.01% 2241
2018
Q4
$274K Buy
13,606
+1,173
+9% +$23.6K ﹤0.01% 2077
2018
Q3
$309K Hold
12,433
﹤0.01% 2132
2018
Q2
$341K Buy
12,433
+2,041
+20% +$56K ﹤0.01% 2072
2018
Q1
$320K Hold
10,392
﹤0.01% 2069
2017
Q4
$372K Hold
10,392
﹤0.01% 2019
2017
Q3
$286K Hold
10,392
﹤0.01% 2190
2017
Q2
$274K Buy
+10,392
New +$274K ﹤0.01% 2221
2016
Q1
Sell
-5,920
Closed -$202K 2530
2015
Q4
$202K Buy
+5,920
New +$202K ﹤0.01% 2271
2015
Q3
Sell
-7,579
Closed -$242K 2607
2015
Q2
$242K Buy
+7,579
New +$242K ﹤0.01% 2395